â-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ... Clinical Infectious Diseases 52 (6), 750-770, 2011 | 695 | 2011 |
High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury Y Sakr, JL Vincent, K Reinhart, J Groeneveld, A Michalopoulos, ... Chest 128 (5), 3098-3108, 2005 | 554 | 2005 |
The revival of fosfomycin AS Michalopoulos, IG Livaditis, V Gougoutas International journal of infectious diseases 15 (11), e732-e739, 2011 | 526 | 2011 |
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic AS Michalopoulos, S Tsiodras, K Rellos, S Mentzelopoulos, ME Falagas Clinical microbiology and infection 11 (2), 115-121, 2005 | 386 | 2005 |
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients ME Falagas, PI Rafailidis, E Ioannidou, VG Alexiou, DK Matthaiou, ... International journal of antimicrobial agents 35 (2), 194-199, 2010 | 377 | 2010 |
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria ME Falagas, IA Bliziotis, SK Kasiakou, G Samonis, P Athanassopoulou, ... BMC infectious diseases 5, 1-7, 2005 | 357 | 2005 |
Potential of old-generation antibiotics to address current need for new antibiotics ME Falagas, AP Grammatikos, A Michalopoulos Expert review of anti-infective therapy 6 (5), 593-600, 2008 | 356 | 2008 |
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study ME Falagas, PI Rafailidis, D Kofteridis, S Virtzili, FC Chelvatzoglou, ... Journal of antimicrobial chemotherapy 60 (5), 1124-1130, 2007 | 338 | 2007 |
Treatment of Acinetobacter infections A Michalopoulos, ME Falagas Expert opinion on pharmacotherapy 11 (5), 779-788, 2010 | 290 | 2010 |
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis SK Kasiakou, A Michalopoulos, ES Soteriades, G Samonis, GJ Sermaides, ... Antimicrobial agents and chemotherapy 49 (8), 3136-3146, 2005 | 275 | 2005 |
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis A Michalopoulos, SK Kasiakou, Z Mastora, K Rellos, AM Kapaskelis, ... Critical Care 9, 1-7, 2005 | 263 | 2005 |
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study A Michalopoulos, D Fotakis, S Virtzili, C Vletsas, S Raftopoulou, Z Mastora, ... Respiratory medicine 102 (3), 407-412, 2008 | 259 | 2008 |
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation A Michalopoulos, S Virtzili, P Rafailidis, G Chalevelakis, M Damala, ... Clinical microbiology and infection 16 (2), 184-186, 2010 | 256 | 2010 |
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials SK Kasiakou, GJ Sermaides, A Michalopoulos, ES Soteriades, ... The Lancet Infectious Diseases 5 (9), 581-589, 2005 | 244 | 2005 |
The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature ME Falagas, SK Kasiakou, S Tsiodras, A Michalopoulos Clinical medicine & research 4 (2), 138-146, 2006 | 228 | 2006 |
Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study DK Matthaiou, A Michalopoulos, PI Rafailidis, DE Karageorgopoulos, ... Critical care medicine 36 (3), 807-811, 2008 | 226 | 2008 |
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study IP Korbila, A Michalopoulos, PI Rafailidis, D Nikita, G Samonis, ... Clinical microbiology and infection 16 (8), 1230-1236, 2010 | 219 | 2010 |
Nephrotoxicity of intravenous colistin: a prospective evaluation ME Falagas, KN Fragoulis, SK Kasiakou, GJ Sermaidis, A Michalopoulos International journal of antimicrobial agents 26 (6), 504-507, 2005 | 215 | 2005 |
Toxicity after prolonged (more than four weeks) administration of intravenous colistin ME Falagas, M Rizos, IA Bliziotis, K Rellos, SK Kasiakou, ... BMC infectious diseases 5, 1-8, 2005 | 204 | 2005 |
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients ME Falagas, PI Rafailidis, DK Matthaiou, S Virtzili, D Nikita, ... International journal of antimicrobial agents 32 (5), 450-454, 2008 | 201 | 2008 |